OBIO — Orchestra BioMed Holdings, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1814114 ·
Last close
$3.98
Market Cap
$238.33M
52W High
$4.80
52W Low
$3.56
ADV30
406,173
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 110,000 | 78,000 | -22,076,000 | -20,691,000 | 100,658,000 | 28,367,000 | 59,466,000 |
| Dec 2025 | 30,917,000 | 30,866,000 | 6,754,000 | 6,245,000 | 114,857,000 | 34,690,000 | 61,287,000 |
| Sep 2025 | 861,000 | 812,000 | -20,313,000 | -20,828,000 | 104,807,000 | 42,012,000 | 61,068,000 |
| Jun 2025 | 836,000 | 790,000 | -19,327,000 | -19,363,000 | 42,825,000 | 18,749,000 | 42,530,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-54,515,000
Investing CF
$-29,622,000
Financing CF
$94,156,000
CapEx
$-561,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.72
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-383,270,000
Inventory
$277,000
Receivables
$84,000
ST Investments
$66,033,000
EBIT TTM
$-54,708,000
Pretax Income TTM
$-54,637,000
Interest Exp TTM
—
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$32,724,000
EBITDA
$-54,628,000
Free Cash Flow
$-25,462,000
Enterprise Value
$169,546,240
Total Cash
$94,400,000
Total Debt
$15,848,000
Shares Out
59,880,715
Trailing EPS
$-0.95
Book Value
$0.70
ROE
-161.1%
ROA
-43.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 33,482,000 | -51,807,000 | -52,701,000 | 114,857,000 | 61,287,000 | — | -48,963,000 |
| Dec 2024 | 2,638,000 | -64,301,000 | -61,024,000 | 76,173,000 | 43,215,000 | — | -50,558,000 |
| Dec 2023 | 2,760,000 | -51,506,000 | -49,120,000 | 95,212,000 | 27,169,000 | — | -46,127,000 |
| Dec 2022 | 3,533,000 | -32,657,000 | -33,608,000 | 95,572,000 | 43,038,000 | — | -29,289,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.46
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| UTMD | UTAH MEDICAL PRODUCTS INC | $224.54M | $70.52 | — |
| ANIK | Anika Therapeutics, Inc. | $258.02M | $19.28 | — |
| EMBC | Embecta Corp. | $215.95M | $3.64 | — |
| PROF | Profound Medical Corp. | $268.17M | $7.38 | — |
| TLSI | TriSalus Life Sciences, Inc. | $278.83M | $4.54 | — |
News headlines (Yahoo Finance, 1h cache)
Orchestra BioMed Joins Russell 3000® and Russell 2000® Indexes
2026-06-29 12:00 · Yahoo
Sidoti Events, LLC's June Small-Cap Virtual Conference
2026-06-16 14:00 · Yahoo
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-06-02 20:05 · Yahoo
Favourable Signals For Orchestra BioMed Holdings: Numerous Insiders Acquired Stock
2026-05-21 11:10 · Yahoo
Orchestra BioMed to Participate in the Jefferies Global Healthcare Conference
2026-05-19 12:30 · Yahoo
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Lags Revenue Estimates
2026-05-12 21:40 · Yahoo
Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates
2026-05-12 20:18 · Yahoo
Orchestra BioMed Targeting BACKBEAT Trial Enrollment Completion By End of Q3 2026 and Data Presentation in Q2 2027
2026-05-12 12:30 · Yahoo
Stoke Therapeutics, Inc. (STOK) Reports Q1 Loss, Tops Revenue Estimates
2026-05-07 23:05 · Yahoo
TScan Therapeutics, Inc. (TCRX) Reports Q1 Loss, Lags Revenue Estimates
2026-05-06 12:25 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.